Filing Flows › Coya Therapeutics (COYA) › Q2 2026 › vs Q2 2025
Coya Therapeutics (COYA) Q2 2026 vs Q2 2025 (year over year)
Coya Therapeutics's revenue rose $80K (+49%) from $164K in Q2 2025 to $244K in Q2 2026.
Coya Therapeutics, Q2 2026: revenue $244K (+49% year over year), net loss $6.6M, operating cash flow −$7.4M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $244K | $164K | $80K | +49% |
| Other income, net | $409K | $320K | $89K | +28% |
| Net loss | $6.6M | $6.1M | $543K | +9% |
| Costs & expenses | $7.3M | $6.6M | $713K | +11% |
| Operating costs | $7.3M | $6.6M | $713K | +11% |
| Research & development | $5.0M | $3.7M | $1.4M | +37% |
| General & admin | $2.3M | $2.9M | −$653K | -22% |
| Operating cash sources | $8.3M | $6.8M | $1.5M | +22% |
| Depreciation | $3K | $7K | −$4K | -59% |
| Share-based compensation | $944K | $1.0M | −$92K | -9% |
| Cash used in operations | $7.4M | $5.8M | $1.6M | +28% |
| Net loss absorbed | $6.6M | $6.1M | $543K | +9% |
| Working capital & other | $1.7M | $721K | $964K | +134% |
Questions
How much did Coya Therapeutics's revenue grow year over year in Q2 2026?
Coya Therapeutics's revenue rose $80K (+49%) from $164K in Q2 2025 to $244K in Q2 2026.